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 How does clinical decision support (CDS) improve quality of care? 
The goal of this project is to use the CDS recently implemented into the 
electronic health record at Lehigh Valley Health Network (LVHN) for the 
prevention of neonatal group B streptococcus disease as an example of 
clinical decision support and how it can improve the quality of a health 
system. 
 Quality clinical care is an essential measure of success of a 
healthcare system. One method of particular interest for improving 
quality of care is CDS, defined as the use of information and 
communication technologies to bring relevant knowledge to bear on the 
health care and well-being of a patient2. One cause of this interest in 
healthcare technology is U.S. legislation enacted in 2009, which 
incentivized the healthcare industry to adopt or improve electronic health 
record (EHR) systems and demonstrate their meaningful use. CDS plays 
an important role in fulfilling stage two and three EHR Meaningful Use 
criteria.  
 A simple but valuable CDS tool is data entry validation, for example, 
setting predefined limits in a computer-based provider order entry. This 
could inhibit a physician from accidently requesting ten times the 
intended medication dosage. More complex CDS tools include 
applications that aid in constructing a differential diagnosis or selecting 
an optimal treatment strategy. An example of one of these high level 
tools is the CDS involved in the prevention of neonatal Group B 
streptococcal disease, and it will be examined in detail.  
 Group B streptococcal (GBS) disease is the most common infectious 
cause of neonatal morbidity and mortality in the U.S. The Center for 
Disease Control and Prevention (CDC) developed a CDS tool based on 
their 2010 guideline for the prevention of neonatal GBS disease that 
assists providers in improving guideline compliance. This ensures 
pregnant patients in labor receive the proper standard of care, and 
neonatal GBS disease cases are prevented.  
 Despite significant promise, CDS continues to be underutilized, with 
only 34.4% of non-federal acute care hospitals using EHRs with 
advanced CDS features1. A cause for this underutilization is that many 
EHRs do not have the complex programming capabilities necessary for 
CDS application4, but this deficit can be overcome by using external 
operating systems. Web-based development platforms along with 
vender-supported application programming interfaces have been shown 
to be feasible7, but the CDS implemented at LVHN goes a step further 
with complete integration within the EHR.  
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Plan: 
 The GBS prevention tool was selected as a representative CDS 
because there is a well-documented, but complex guideline under which 
the CDS could be built, the CDS integration into the EHR at LVHN 
demonstrates the challenges of implementation, and room for improved 
outcomes for GBS disease still exist. A recent review of early-onset GBS 
cases, GBS disease in neonates less than seven days old, found that 
25% of the cases contained at least one implementation error in the use 
of intrapartum prophylaxis when indicated6. 
 The LVHN Department of Obstetrics and Gynecology is currently 
studying the clinical effectiveness of the implemented CDS in improving 
the delivery of guideline concordant GBS prophylaxis. The retrospective 
cohort study will compare how patients in labor were treated for the 
prevention GBS sepsis in the newborn following the implementation of 
the CDS for six months compared to a similar time period prior to the 
availability of the CDS system.  
 Characteristics of the GBS prevention tool that may have influenced 
its effectiveness will also be evaluated using literature review.  
Act / Conclusions: 
 CDS systems will almost certainly continue to be important aspects of 
EHR systems, and their development, integration and clinical significance 
will play essential roles in their ability to improve quality of care.  
 The GBS CDS utilizes two clinically significant general system features 
correlated with CDS success based on systematic review: integration into 
the charting or order entry system and computer-based generation of 
decision support. Benefits of creating a highly integrated CDS, that is, an 
interface integrated within an EHR, are that it is easily accessible and visible 
to the provider, and that it provides the platform for efficient data extraction 
and information output.  
 The third clinically significant feature of the GBS tool is its ability to 
automatically provide decision support as a part of clinician workflow. This 
feature applies to the GBS CDS because the clinician has access to 
pertinent information through the EHR, they are prompted to use the CDS at 
the appropriate time, and they receive the results immediately. Because this 
project does not include an encompassing analysis of workflow5, the 
evaluation of how well this CDS fits into clinician workflow is a potential 
oversimplification.  
 The only clinically significant provision the GBS CDS does not follow is 
request for documentation of reason for not following system 
recommendations. The probable cause being that the CDS requires all 
information for guideline adherence; there would not likely be a defendable 
reason to challenge the recommendation. Though there certainly are 
circumstances that lead to non-adherence such as incorrect CDS input 
information, or a patient delivering before recommendations are carried out, 
these types of cases are outside the scope of this project.  
 At this point, external algorithm processing is necessary to overcome 
deficiencies in available EHRs, but an additional benefit of the model used 
for this CDS is that the same organization that created the guideline also 
built the CDS used to follow it. This attribute enforces usage of the guideline 
in the manner the CDC intended it, and facilitates keeping the CDS up-to-
date in conjuncture with updated guidelines. One final benefit of the unique 
implementation of the GBS tool at LVHN is that the CDC receives the data 
in real-time, which they are able to use in population based studies. The 
model used for the GBS CDS at LVHN has the potential for broad 
application with the end oal of im roving the delivery of quality healthcare 
and ensuring patient safety.  
 Limitations of this study include utilization of only one systematic 
review3, which examin d varying types f CDS. The features n cessary for 
success of these CDS tools may be different from more complex, treatment 
strategy recommendations or computerized guideline support. Another 
limitation i the research examining the effectiveness of the GBS CDS is not 
yet complete. Demonstrated effectiveness of this CDS tool will strongly 
support the recommendation that this tool is useful and its implementation 
was effective. Next steps include exami ing the results of th  research 
assessing effectiveness of the CDS, monitoring the status of the CDS as 
LVHN transitions to the EHR Epic, and continuing to monitor provider 
utilization of the CDS.  
 
Jane Bigelow and David McLean, MD 
Lehigh Valley Health Network, Allentown PA 
Literature cited: 
[1] Charles, D., Gabriel, M. & Searcy, T. (2015) Adoption of Electronic Health Record Systems among U.S. Non- Federal 
Acute Care Hospitals: 2008-2014. ONC Data Brief No. 23 Available from: http://healthit.gov/sites/default/files/data-
brief/2014HospitalAdoptionDataBrief.pdf 
[2] Greenes, R. (2014). Clinical Decision Support and the Road to Broad Adoption (Second ed.). Amsterdam: Elsevier/AP. 
[3] Kawamoto, K., Houlihan, C. A., Balas, E. A., & Lobach, D.F. (2005). Improving clinical practice using clinical decision 
support systems: a systematic review of trials to identify features critical to success. BMJ 2005;330:765 doi: 
http://dx.doi.org/10.1136/bmj.38398.500764.8F 
[4] McCoy, A.B., Wright, A. & Sittig, D.F. (2015) Cross-Vendor evaluation of key user-defined clinical decision support 
capabilities: A scenario-based assessment of certified electronic health records with guidelines for future development. 
JAMIA. doi: 10.1093/jamia/ocv073 
[5] Osheroff, J. A., Teich, J. M., Levick, D., Saldana, L., Velasco, F. T., Sittig, D. F., Rogers, K. M. & Jenders R. A. (2012) 
Improving Outcomes with Clinical Decision Support: An Implementer's Guide (Second ed.) HIMSS, the Scottsdale 
Institute, AMIA, AMDIS and SHM 
[6] Verani, J., Spina, N.,  Lynfield R. et al. (2014) Early-Onset Group B Streptococcal Disease in the United States: Potential 
for Further Reduction. Obstetrics and Gynecology 2014; 123: 828-37 
[7] Zhang, M., Velasco, F.T., Musser, R.C. & Kawamoto, K. (2013) Enabling Cross-Platform Clinical Decision Support through 
Web-Based Decision Support in Commercial Electronic Health Record Systems: Proposal and Evaluation of Initial 
Prototype Implementations. AMIA Annual Symposium Proceedings. 2013:1558-1567 
 
Implementation of Clinical Decision Support for the 
Prevention of Perinatal Group B Streptococcal Disease: 
A Quality Improvement Perspective 
Study / Results:   
   
Figure 1 displays the provider interface of the CDS at LVHN. The CDS extracts information from different sources within the EHR or requires the provider 
to input the information. The information is then transferred to the CDC headquarters in Atlanta, GA, where the algorithm program processes the data. 
Figures 2 and 3, taken from the 2010 CDC guideline, depict two parts of the GBS prevention algorithm: under what circumstance antibiotic prophylaxis is 
indicated, and which antibiotic to administer, including dosing regimen. These rules are the basis for the algorithm program.  
The CDC recommendation then appears to the LVHN provider, and example of which is shown in Figure 4.  
 
A literature search of clinical decision support, computer-interpretable guideline, and quality was performed, and a large systematic review of CDS 
tools and their affect on clinical practice3 was selected as a measure. This systematic review included 77 studies, and the differences in success rates 
of the CDS systems with and without 15 potentially important features are depicted in the graph above. Features present in the GBS CDS are 
indicated with a checkmark. The GBS prevention CDS contains three of the four features found to be statistically and clinically significant in this 
systematic review.  
Figure 3: Recommended regimens for intrapartum antibiotic 
prophylaxis for prevention of early-onset GBS disease 
Figure 2: Indications and nonindications for intrapartum antibiotic prophylaxis to prevent early onset GBS 
disease 










Success Rates* of Clinical Decision Support Systems by Feature  
Difference of success rate with
and without features (95% CI)
* Success defined as statistically and clinically significant improvement in clinical practice. 
Figure 4: CDC GBS antibiotic prophylaxis recommendation  
